Beyond Air, Inc. (XAIR) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Beyond Air, Inc.
Address
900 Stewart Avenue
Garden City, NY 11530
United States of America (the)
Phone
516 665 8200
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
54
First IPO Date
June 12, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Robert Scott Goodman | CEO & Director | 157,020 | 1965 |
| Amir Avniel | Chief Executive Officer of NeuroNOS | 412,664 | 1974 |
| Adam Newman | Corporate Secretary | 250,000 | N/A |
| Daniel J. Moorhead | Chief Financial Officer | 317,058 | 1972 |
| Michael A. Gaul | Chief Operating Officer | 396,923 | 1955 |
| Andrew R. Colin | Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board | 0 | N/A |
| John Jett | Head of Research & Clinical Development | 0 | N/A |
| Denton Drewell | Principal Accounting Officer & Controller | 0 | 1987 |
Description
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
